Efficacity of Gefitinib or Erlotinib for EGFR- mutant advanced non-small cell lung carcinoma. Tuj-hlth [Internet]. 2022 Jan. 17 [cited 2026 Nov. 1];43(6):25-32. Available from: https://journal.latakia-univ.edu.sy/index.php/hlthscnc/article/view/11534